| Registered number |
| Registered number: | |||||||
| Balance Sheet | |||||||
| as at |
|||||||
| Notes | 2024 | 2023 | |||||
| £ | £ | ||||||
| Fixed assets | |||||||
| Investments | 3 | ||||||
| Current assets | |||||||
| Debtors | 4 | - | |||||
| Cash at bank and in hand | |||||||
| Creditors: amounts falling due within one year | 5 | ( |
( |
||||
| Net current liabilities | ( |
( |
|||||
| Net liabilities | ( |
( |
|||||
| Capital and reserves | |||||||
| Called up share capital | |||||||
| Profit and loss account | ( |
( |
|||||
| Shareholders' funds | ( |
( |
|||||
| PJ Gamby | |||||||
| Director | |||||||
| Approved by the board on |
|||||||
| Notes to the Accounts | ||||||||
| for the year ended |
||||||||
| 1 | Accounting policies | |||||||
| Basis of preparation | ||||||||
| Turnover | ||||||||
| Investments | ||||||||
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss. |
||||||||
| Investments in associates | ||||||||
Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition. |
||||||||
| Stocks | ||||||||
| Impairment of fixed assets | ||||||||
For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units. |
||||||||
| Creditors | ||||||||
| Taxation | ||||||||
| Impairment of fixed assets | ||||||||
Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition. A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units. |
||||||||
| Financial instruments | ||||||||
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. |
||||||||
| 2 | Employees | 2024 | 2023 | |||||
| Number | Number | |||||||
| Average number of persons employed by the company | ||||||||
| 3 | Investments | £ | ||||||
| Other investments other than loans | ||||||||
| Cost | ||||||||
| At 1 October 2023 | ||||||||
| At 30 September 2024 | ||||||||
| Impairment | ||||||||
| At 30 September 2024 | - | |||||||
| Carrying amount | ||||||||
| At 30 September 2024 | ||||||||
| At 30 September 2023 | ||||||||
| 4 | Debtors | 2024 | 2023 | |||||
| £ | £ | |||||||
| Other debtors | - | |||||||
| 5 | Creditors: amounts falling due within one year | 2024 | 2023 | |||||
| £ | £ | |||||||
| Trade creditors | ||||||||
| Amounts owed to group undertakings and undertakings in which the company has a participating interest | ||||||||
| Other creditors | - | |||||||
| Included in other creditors, an amount due of £880,000 for an overage agreement signed in December 2022. This amount is subordinated to the secured lenders. The liability falls due for payment after the the group’s secured lender is paid in full . |
||||||||
| 6 | Other information | |||||||
| The Chimes Broxbourne Limited is a private company limited by shares and incorporated in England. Its registered office is: | ||||||||
| Building 3 NLBP | ||||||||
| Oakleigh Road South | ||||||||
| New Southgate | ||||||||
| London | ||||||||
| N11 1GN | ||||||||